These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 25148095

  • 1. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
    Reina-Doreste Y, Stern JA, Keene BW, Tou SP, Atkins CE, DeFrancesco TC, Ames MK, Hodge TE, Meurs KM.
    J Am Vet Med Assoc; 2014 Sep 01; 245(5):534-9. PubMed ID: 25148095
    [Abstract] [Full Text] [Related]

  • 2. Effect of oral administration of pimobendan in cats with heart failure.
    Gordon SG, Saunders AB, Roland RM, Winter RL, Drourr L, Achen SE, Hariu CD, Fries RC, Boggess MM, Miller MW.
    J Am Vet Med Assoc; 2012 Jul 01; 241(1):89-94. PubMed ID: 22720992
    [Abstract] [Full Text] [Related]

  • 3. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL.
    J Vet Cardiol; 2011 Dec 01; 13(4):251-60. PubMed ID: 22030289
    [Abstract] [Full Text] [Related]

  • 4. Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.
    Schober KE, Rush JE, Luis Fuentes V, Glaus T, Summerfield NJ, Wright K, Lehmkuhl L, Wess G, Sayer MP, Loureiro J, MacGregor J, Mohren N.
    J Vet Intern Med; 2021 Mar 01; 35(2):789-800. PubMed ID: 33543810
    [Abstract] [Full Text] [Related]

  • 5. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
    Oldach MS, Ueda Y, Ontiveros ES, Fousse SL, Visser LC, Stern JA.
    BMC Vet Res; 2021 Feb 23; 17(1):89. PubMed ID: 33622315
    [Abstract] [Full Text] [Related]

  • 6. Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.
    Ward JL, Kussin EZ, Tropf MA, Tou SP, DeFrancesco TC, Keene BW.
    J Vet Intern Med; 2020 Nov 23; 34(6):2211-2222. PubMed ID: 33026124
    [Abstract] [Full Text] [Related]

  • 7. A review of the pharmacology and clinical uses of pimobendan.
    Boyle KL, Leech E.
    J Vet Emerg Crit Care (San Antonio); 2012 Aug 23; 22(4):398-408. PubMed ID: 22928748
    [Abstract] [Full Text] [Related]

  • 8. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999).
    Rush JE, Freeman LM, Fenollosa NK, Brown DJ.
    J Am Vet Med Assoc; 2002 Jan 15; 220(2):202-7. PubMed ID: 12126131
    [Abstract] [Full Text] [Related]

  • 9. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Jan 15; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 10. Pimobendan in heart failure therapy--a silver bullet?
    Gordon SG, Miller MW, Saunders AB.
    J Am Anim Hosp Assoc; 2006 Jan 15; 42(2):90-3. PubMed ID: 16527909
    [Abstract] [Full Text] [Related]

  • 11. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.
    Fox PR, Keene BW, Lamb K, Schober KA, Chetboul V, Luis Fuentes V, Wess G, Payne JR, Hogan DF, Motsinger-Reif A, Häggström J, Trehiou-Sechi E, Fine-Ferreira DM, Nakamura RK, Lee PM, Singh MK, Ware WA, Abbott JA, Culshaw G, Riesen S, Borgarelli M, Lesser MB, Van Israël N, Côté E, Rush JE, Bulmer B, Santilli RA, Vollmar AC, Bossbaly MJ, Quick N, Bussadori C, Bright JM, Estrada AH, Ohad DG, Fernández-Del Palacio MJ, Lunney Brayley J, Schwartz DS, Bové CM, Gordon SG, Jung SW, Brambilla P, Moïse NS, Stauthammer CD, Stepien RL, Quintavalla C, Amberger C, Manczur F, Hung YW, Lobetti R, De Swarte M, Tamborini A, Mooney CT, Oyama MA, Komolov A, Fujii Y, Pariaut R, Uechi M, Tachika Ohara VY.
    J Vet Intern Med; 2018 May 15; 32(3):930-943. PubMed ID: 29660848
    [Abstract] [Full Text] [Related]

  • 12. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy.
    Rush JE, Freeman LM, Brown DJ, Smith FW.
    J Am Anim Hosp Assoc; 1998 May 15; 34(1):38-41. PubMed ID: 9527429
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 May 15; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 14. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P.
    J Vet Intern Med; 2016 Nov 15; 30(6):1765-1779. PubMed ID: 27678080
    [Abstract] [Full Text] [Related]

  • 15. Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.
    Yang VK, Rush JE, Bhasin S, Wagers AJ, Lee RT.
    J Vet Cardiol; 2019 Oct 15; 25():41-51. PubMed ID: 31568985
    [Abstract] [Full Text] [Related]

  • 16. Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy.
    Hambrook LE, Bennett PF.
    J Feline Med Surg; 2012 Apr 15; 14(4):233-9. PubMed ID: 22412159
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of red blood cell distribution width in cats with hypertrophic cardiomyopathy.
    Stanzani G, Cowlam R, English K, Connolly DJ.
    J Vet Cardiol; 2015 Dec 15; 17 Suppl 1():S233-43. PubMed ID: 26776582
    [Abstract] [Full Text] [Related]

  • 18. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D, Fry D.
    Compend Contin Educ Vet; 2011 Nov 15; 33(11):E1. PubMed ID: 22101450
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study).
    Summerfield NJ, Boswood A, O'Grady MR, Gordon SG, Dukes-McEwan J, Oyama MA, Smith S, Patteson M, French AT, Culshaw GJ, Braz-Ruivo L, Estrada A, O'Sullivan ML, Loureiro J, Willis R, Watson P.
    J Vet Intern Med; 2012 Nov 15; 26(6):1337-49. PubMed ID: 23078651
    [Abstract] [Full Text] [Related]

  • 20. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 15; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.